# The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)

> **NCT01016210** · PHASE4 · COMPLETED · sponsor: **The Baruch Padeh Medical Center, Poriya** · enrollment: 60 (estimated)

## Conditions studied

- Pregnancy Result Rape

## Interventions

- **DRUG:** Leuveris
- **DRUG:** Leuveris

## Key facts

- **NCT ID:** NCT01016210
- **Lead sponsor:** The Baruch Padeh Medical Center, Poriya
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-03
- **Final completion:** 2013-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016210, "The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01016210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*